Latest / IMA (Formerly FLCCC Alliance)
DrBeen#75 Hydroxychloroquine Reduces Mortality by 35% in Hospitalized COVID-19 Patients
This study from Belgium demonstrates that the use of standard/low dose hydroxychloroquine and azithromycin (macrolide) in hospitalized COVID-19 patients reduces the risk of mortality by 35%. Let's review.
DrBeen: Medical Education Online
https://www.drbeen.com/
FLCCC | Front Line COVID-19 Critical Care Alliance
https://covid19criticalcare.com/
URL list (Oct. 12, 2023)
Efficacy and safety of in-hospital treatment of Covid-19 infection with low-dose hydroxychloroquine and azithromycin in hospitalized patients: A retrospective controlled cohort study - ScienceDirect…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.